RMTI
Rockwell Medical, Inc.
$5.60
+0.06 (+1.08%)
At close · Jul 6
Market Cap
$221.03M
Shares
39,470,299
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.60
Open$5.43
Day$5.39–5.71
52W$4.89–21.00
Avg vol 30d41K
Short int734K · 1.9% float · 1.9d
Short vol46%
Last earningsMay 7, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 7
Equibles Rating
blended score · not investment advice
Overall
Sell
Technical · trend & momentum
Strong Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−41% below
−
Price vs 50-day avg
−24% below
◦
RSI (14)
34 · neutral
−
MACD trend
negative
−
52-week position
4% · near low
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $7 › 200d $9 — 200d above 50d
+
Institutional flow
+16% holders QoQ · +13 funds added
◦
Insider flow
No net insider activity over 90 days
−
Short interest
1.86% of float · ▲ +91.2% MoM · 1.9 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
43 holders — mid 3-yr range
Fundamentals
Fair
−
EPS growth
−400% Y/Y
+
Balance sheet
net cash $10.7M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 7, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance & track record
Latest guidance
· from the 8-K filed May 7, 2026
Net Sales
· 2026 Annual
Maintained
$70M – $75M
Gross Margin
· 2026 Annual
Maintained
18% – 22%
Adjusted EBITDA
· 2026 Annual
Non-GAAP
Maintained
$1M – $2M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−41% below
Bearish
Price vs 50-day avg
−24% below
Bearish
RSI (14)
34 · neutral
Neutral
MACD trend
negative
Bearish
52-week position
4% · near low
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $7 › 200d $9 — 200d above 50d
Institutional flow
Accumulating
+16% holders QoQ · +13 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.86% of float · ▲ +91.2% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
43 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $5
Now $6 · 4%
52-wk high $21
vs 200-day avg -41%
vs 50-day avg -24%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Gross margin | 17% | three months ended March 31 | — |
| countries supplied outside the United States | 30 | Q1 FY2026 call | — |
| customers | 300 | Q1 FY2026 call | — |
| facilities | 1,400 | Q1 FY2026 call | — |
| Adjusted EBITDA non-GAAP | $0.3M | twelve months ended December 31, 2025 | — |
| Cash flow from operating activities | $2.3M | fourth quarter 2025 | — |
| cash flow from operations | $2.3M | Q4 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RMTI
this stock
Rockwell Medical, Inc.
|
$221.03M | -32.8% | — | — | 1.9% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$53.73B | +8.3% | — | — | 0.2% |
|
GALDY
Galderma Group AG/ADR
|
$51.93B | +6.8% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$42.80B | -3.9% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RMTI | -14.0% | -19.7% | -40.3% | +1.7% | -32.8% |
| SPY | +3.1% | -0.8% | +8.2% | +0.6% | +10.2% |
| vs SPY | -17.0% | -18.9% | -48.5% | +1.1% | -43.0% |